Cornerstone Planning Group LLC Axonics, Inc. Transaction History
Cornerstone Planning Group LLC
- $378 Billion
- Q3 2024
A detailed history of Cornerstone Planning Group LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 71 shares of AXNX stock, worth $4,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71
Previous 71
-0.0%
Holding current value
$4,996
Previous $4.87 Million
2.34%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
236Shares Held
42.7MCall Options Held
73.7KPut Options Held
230K-
Vanguard Group Inc Valley Forge, PA5.04MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$306 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.11MShares$148 Million6.8% of portfolio
-
Fil LTD Hamilton, D02.04MShares$144 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$125 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.46B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...